These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33655382)

  • 21. Percutaneous coronary intervention compared with coronary artery bypass graft in coronary artery disease patients with chronic kidney disease: a systematic review and meta-analysis.
    Ren X; Liu W; Peng Y; Li Q; Chai H; Zhao ZG; Meng QT; Chen C; Zhang C; Luo XL; Chen M; Huang DJ
    Ren Fail; 2014 Sep; 36(8):1177-86. PubMed ID: 24986458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Appropriate therapy for patients with stable ischemic heart disease: a review of literature and the implication of the International Study of Comparative Effectiveness with Medical and Invasive Approaches trial.
    Guo MH; Nantsios A; Ruel M
    Curr Opin Cardiol; 2020 Nov; 35(6):658-663. PubMed ID: 32941193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Clinical Outcomes Following Revascularization in High-Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease.
    Bainey KR; Alemayehu W; Welsh RC; Kumar A; King SB; Kirtane AJ
    J Am Heart Assoc; 2021 Jan; 10(1):e018104. PubMed ID: 33342230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications of the Landmark ISCHEMIA Trial on the Initial Management of High-Risk Patients with Stable Ischemic Heart Disease.
    Vafaei P; Naderi S; Ambrosy AP; Slade JJ
    Curr Atheroscler Rep; 2021 Sep; 23(11):70. PubMed ID: 34468881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kidney function modifies the selection of treatment strategies and long-term survival in stable ischaemic heart disease: insights from the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) registry.
    Shavadia JS; Southern DA; James MT; Welsh RC; Bainey KR
    Eur Heart J Qual Care Clin Outcomes; 2018 Oct; 4(4):274-282. PubMed ID: 29106471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.
    Stone GW; Hochman JS; Williams DO; Boden WE; Ferguson TB; Harrington RA; Maron DJ
    J Am Coll Cardiol; 2016 Jan; 67(1):81-99. PubMed ID: 26616030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revascularization options in stable coronary artery disease: it is not how to revascularize, it is whether and when to revascularize.
    Torosoff MT; Sidhu MS; Desai KP; Fein SA; Boden WE
    J Comp Eff Res; 2015 Sep; 4(5):505-14. PubMed ID: 26387530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial).
    Bradley SM; Chan PS; Hartigan PM; Nallamothu BK; Weintraub WS; Sedlis SP; Dada M; Maron DJ; Kostuk WJ; Berman DS; Teo KK; Mancini GB; Boden WE; Spertus JA
    Am J Cardiol; 2015 Jul; 116(2):167-73. PubMed ID: 25960375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease.
    Roberts JK; Rao SV; Shaw LK; Gallup DS; Marroquin OC; Patel UD
    Am J Cardiol; 2017 May; 119(9):1344-1351. PubMed ID: 28318510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of Life in Older Adults With Stable Ischemic Heart Disease and Diabetes Mellitus: A Post Hoc Analysis of the BARI 2D Trial.
    Park DY; Jamil Y; Moumneh MB; Batchelor B W; Nanna MG; Damluji AA
    Am J Cardiol; 2024 Jul; 223():58-69. PubMed ID: 38797195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial Invasive or Conservative Strategy for Stable Coronary Disease.
    Maron DJ; Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Boden WE; Chaitman BR; Senior R; López-Sendón J; Alexander KP; Lopes RD; Shaw LJ; Berger JS; Newman JD; Sidhu MS; Goodman SG; Ruzyllo W; Gosselin G; Maggioni AP; White HD; Bhargava B; Min JK; Mancini GBJ; Berman DS; Picard MH; Kwong RY; Ali ZA; Mark DB; Spertus JA; Krishnan MN; Elghamaz A; Moorthy N; Hueb WA; Demkow M; Mavromatis K; Bockeria O; Peteiro J; Miller TD; Szwed H; Doerr R; Keltai M; Selvanayagam JB; Steg PG; Held C; Kohsaka S; Mavromichalis S; Kirby R; Jeffries NO; Harrell FE; Rockhold FW; Broderick S; Ferguson TB; Williams DO; Harrington RA; Stone GW; Rosenberg Y;
    N Engl J Med; 2020 Apr; 382(15):1395-1407. PubMed ID: 32227755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
    Shaw LJ; Berman DS; Maron DJ; Mancini GB; Hayes SW; Hartigan PM; Weintraub WS; O'Rourke RA; Dada M; Spertus JA; Chaitman BR; Friedman J; Slomka P; Heller GV; Germano G; Gosselin G; Berger P; Kostuk WJ; Schwartz RG; Knudtson M; Veledar E; Bates ER; McCallister B; Teo KK; Boden WE;
    Circulation; 2008 Mar; 117(10):1283-91. PubMed ID: 18268144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease.
    Charytan DM; Desai M; Mathur M; Stern NM; Brooks MM; Krzych LJ; Schuler GC; Kaehler J; Rodriguez-Granillo AM; Hueb W; Reeves BC; Thiele H; Rodriguez AE; Buszman PP; Buszman PE; Maurer R; Winkelmayer WC
    Kidney Int; 2016 Aug; 90(2):411-421. PubMed ID: 27259368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal Medical Treatment vs. Invasive Approach in Patients with Significantly Obstructive Coronary Artery Disease and Ischemia.
    Carvajal-Juarez I; Espínola-Zavaleta N; Antonio-Villa NE; Keirns C; Alexanderson-Rosas E
    Arch Med Res; 2020 Jul; 51(5):413-418. PubMed ID: 32327292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
    Maron DJ; Spertus JA; Mancini GB; Hartigan PM; Sedlis SP; Bates ER; Kostuk WJ; Dada M; Berman DS; Shaw LJ; Chaitman BR; Teo KK; O'Rourke RA; Weintraub WS; Boden WE;
    Am J Cardiol; 2009 Oct; 104(8):1055-62. PubMed ID: 19801024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
    Morrison DA; Sacks J
    Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolving concepts in selecting optimal strategies for the management of patients with stable coronary disease: pharmacologic or revascularization therapy.
    Tandar A; Boden WE
    Curr Opin Cardiol; 2009 Nov; 24(6):591-5. PubMed ID: 19752728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in geographic variation in the use of percutaneous coronary intervention for stable ischemic heart disease after publication of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.
    Mohan AV; Fazel R; Huang PH; Shen YC; Howard D
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):125-30. PubMed ID: 24347661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ischemia Trial: Does the Cardiology Community Need to Pivot or Continue Current Practices?
    Jafary FH; Jafary AH
    Curr Cardiol Rep; 2022 Aug; 24(8):1059-1068. PubMed ID: 35653055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.